Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Astex Pharmaceuticals, Inc. (ASTX)

-NasdaqGS

5.36 Up 0.24(4.69%) May 24, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 83,159   66,914   52,972  
Cost of Revenue -   -   -  
Gross Profit 83,159   66,914   52,972  
Operating Expenses
Research Development60,418  43,895  28,394  
Selling General and Administrative15,662  16,842  9,442  
Non Recurring7,402  1,250   -  
Others8,005  3,215   -  
Total Operating Expenses91,487  65,202   -  
Operating Income or Loss (7,052) 2,412   15,886  
Income from Continuing Operations
Total Other Income/Expenses Net3,543  542  1,176  
Earnings Before Interest And Taxes(4,785)2,254  16,312  
Interest Expense -   -   -  
Income Before Tax(4,785)2,254  16,312  
Income Tax Expense(13,032)(3,288)39  
Minority Interest -   -   -  
Net Income From Continuing Ops8,247  5,542  16,273  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 8,247   5,542   16,273  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 8,247   5,542   16,273  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.